Published in Clin Biochem on November 10, 2009
Activation of the receptor for advanced glycation end products system in women with severe preeclampsia. J Clin Endocrinol Metab (2011) 0.87
Reduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetes. BJOG (2012) 0.77
Diagnostic Potential of Evaluation of SDF-1α and sRAGE Levels in Threatened Premature Labor. Biomed Res Int (2016) 0.75
Lower retinol levels as an independent predictor of mortality in long-term hemodialysis patients: a prospective observational cohort study. Am J Kidney Dis (2010) 1.43
Soluble receptor for advanced glycation end products in patients with decreased renal function. Am J Kidney Dis (2006) 1.31
Oxidative stress and signal transduction pathways in alcoholic liver disease. Alcohol Clin Exp Res (2005) 1.16
Receptor for advanced glycation end products (RAGE)--soluble form (sRAGE) and gene polymorphisms in patients with breast cancer. Cancer Invest (2007) 1.07
Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. Mutat Res (2005) 1.05
Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients. Nephrol Dial Transplant (2007) 1.03
Circulating levels of pregnanolone isomers during the third trimester of human pregnancy. J Steroid Biochem Mol Biol (2007) 0.97
A419C (E111A) polymorphism of the glyoxalase I gene and vascular complications in chronic hemodialysis patients. Ann N Y Acad Sci (2007) 0.95
Biochemical oxidative stress-related markers in patients with obstructive sleep apnea. Med Sci Monit (2011) 0.93
Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer. Clin Biochem (2010) 0.90
Steroid metabolome in plasma from the umbilical artery, umbilical vein, maternal cubital vein and in amniotic fluid in normal and preterm labor. J Steroid Biochem Mol Biol (2009) 0.88
Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy. J Perinat Med (2006) 0.85
Soluble cytokine receptors in renal vasculitis and lupus nephritis. Med Sci Monit (2002) 0.84
Relationships of circulating pregnanolone isomers and their polar conjugates to the status of sex, menstrual cycle, and pregnancy. J Endocrinol (2007) 0.83
Glycoxidation and inflammation in chronic haemodialysis patients. Nephrol Dial Transplant (2003) 0.83
No benefit of hemodiafiltration over hemodialysis in lowering elevated levels of asymmetric dimethylarginine in ESRD patients. Blood Purif (2006) 0.83
Low maternal serum matrix metalloproteinase (MMP)-2 concentrations are associated with preterm labor and fetal inflammatory response. J Perinat Med (2010) 0.83
Neuroactive pregnanolone isomers during pregnancy. J Clin Endocrinol Metab (2004) 0.83
Advanced glycation end-products in patients with chronic alcohol misuse. Alcohol Alcohol (2004) 0.82
Panel of Urinary Diagnostic Markers for Non-Invasive Detection of Primary and Recurrent Urothelial Urinary Bladder Carcinoma. Urol Int (2015) 0.81
Oxidative stress and endothelium influenced by metformin in type 2 diabetes mellitus. Eur J Clin Pharmacol (2007) 0.81
Does renal function influence plasma levels of advanced glycation and oxidation protein products in patients with chronic rheumatic diseases complicated by secondary amyloidosis? Kidney Blood Press Res (2006) 0.81
Soluble RAGE, diabetic nephropathy and genetic variability in the AGER gene. Arch Physiol Biochem (2008) 0.81
Pathobiochemistry of nephrotic syndrome. Adv Clin Chem (2003) 0.80
Placental growth factor in patients with decreased renal function. Ren Fail (2011) 0.80
Steroid profiling in pregnancy: a focus on the human fetus. J Steroid Biochem Mol Biol (2013) 0.80
Receptor for advanced glycation end products (RAGE) and glyoxalase I gene polymorphisms in pathological pregnancy. Clin Biochem (2012) 0.79
Detection of feto-maternal infection/inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot study. J Perinat Med (2008) 0.79
Evaluation of skin microcirculation during hemodialysis. Ren Fail (2010) 0.79
2,3,7,8-TCDD exposure, endothelial dysfunction and impaired microvascular reactivity. Hum Exp Toxicol (2007) 0.79
Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis patients. Kidney Int Suppl (2003) 0.79
Antiphospholipid antibodies in patients with lupus nephritis. Ren Fail (2003) 0.79
Determination of 17alpha-hydroxypregnenolone sulfate and its application in diagnostics. Steroids (2007) 0.79
Signal transduction in alcohol-related diseases. Alcohol Clin Exp Res (2005) 0.78
Serum S100A12 (EN-RAGE) levels in patients with decreased renal function and subclinical chronic inflammatory disease. Kidney Blood Press Res (2011) 0.78
RAGE polymorphisms, renal function and histological finding at 12 months after renal transplantation. Clin Biochem (2008) 0.78
Pregnancy-associated plasma protein a and soluble receptor for advanced glycation end products after kidney transplantation. Kidney Blood Press Res (2007) 0.78
Pregnancy-associated plasma protein A (PAPP-A) and preeclampsia. Adv Clin Chem (2014) 0.78
Fetal complications due to intrahepatic cholestasis of pregnancy. J Perinat Med (2015) 0.78
Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: calprotectin and IL-6 changes do not correspond to sRAGE changes. Scand J Clin Lab Invest (2010) 0.78
Progesterone, inflammation and preterm labor. J Steroid Biochem Mol Biol (2013) 0.78
Resting energy expenditure and thermal balance during isothermic and thermoneutral haemodialysis--heat production does not explain increased body temperature during haemodialysis. Nephrol Dial Transplant (2007) 0.78
Placental growth factor may predict increased left ventricular mass index in patients with mild to moderate chronic kidney disease--a prospective observational study. BMC Nephrol (2013) 0.78
Intracellular cytokine production in peripheral blood lymphocytes: a comparison of values in infertile and fertile women. Am J Reprod Immunol (2011) 0.77
Advanced glycation end products in myocardial reperfusion injury. Heart Vessels (2011) 0.77
Advanced glycation end products in hemodialyzed patients with diabetes mellitus correlate with leptin and leptin/body fat ratio. Ren Fail (2003) 0.77
Concentrations of sRAGE in serum and follicular fluid in assisted reproductive cycles--a preliminary study. Clin Lab (2010) 0.77
[AGEs and RAGE - advanced glycation end-products and their receptor in questions and answers]. Vnitr Lek (2014) 0.77
Glyoxalase I Glu111Ala polymorphism in patients with breast cancer. Cancer Invest (2009) 0.77
Plasma calprotectin in chronically dialyzed end-stage renal disease patients. Inflamm Res (2009) 0.77
Genetic predisposition to advanced glycation end products toxicity is related to prognosis of chronic hemodialysis patients. Kidney Blood Press Res (2010) 0.77
Polymorphisms of the receptor for advanced glycation end-products and glyoxalase I in patients with renal cancer. Tumour Biol (2014) 0.77
Diagnostic Importance of Selected Protein Serum Markers in the Primary Diagnostics of Prostate Cancer. Urol Int (2015) 0.76
Circulating fetuin-A predicts early mortality in chronic hemodialysis patients. Clin Biochem (2009) 0.76
Influence of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome. Med Sci Monit (2002) 0.76
Associations of serum levels of advanced glycation end products with nutrition markers and anemia in patients with chronic kidney disease. Ren Fail (2011) 0.75
Effect of hemodiafiltration on pregnancy-associated plasma protein A (PAPP-A) and related parameters. Ren Fail (2006) 0.75
Determinants of circulating matrix metalloproteinase-2 and pregnancy-associated plasma protein-A in patients with chronic kidney disease. Clin Lab (2012) 0.75
Low glucose degradation product peritoneal dialysis regimen is associated with lower plasma EN-RAGE and HMGB-1 proinflammatory ligands of receptor for advanced glycation end products. Ther Apher Dial (2014) 0.75
Changes in levels of matrix metalloproteinase-2 and -9, pregnancy-associated plasma protein-A in patients with various nephropathies. J Nephrol (2012) 0.75
Recent progress in the pathogenesis of nephrotic proteinuria. Crit Rev Clin Lab Sci (2008) 0.75
Advanced glycation end products and acute myocardial infarction. Med Princ Pract (2010) 0.75
[Pharmacogenetic aspects of current pharmacotherapy]. Cas Lek Cesk (2010) 0.75
Conducting labor in women with previous caesarean section in a low gestational week. A prospective case-controlled study. Gynecol Obstet Invest (2008) 0.75
[Receptor pro konečné produkty pokročilé glykace (RAGE) - klíčový hráč diabetické angiopatie?]. Vnitr Lek (2014) 0.75
Association of pregnancy-associated plasma protein A polymorphism with preeclampsia - a pilot study. Clin Biochem (2011) 0.75
Diagnostic and prognostic value of presepsin in preterm deliveries. J Matern Fetal Neonatal Med (2014) 0.75
Anti-inflammatory properties of high-density lipoprotein cholesterol in chronic hemodialysis patients: impact of intervention. J Ren Nutr (2010) 0.75
Assessment of features for automatic CTG analysis based on expert annotation. Conf Proc IEEE Eng Med Biol Soc (2011) 0.75
Pregnancy-associated plasma protein A (PAPP-A) and soluble receptor for advanced glycation end products (sRAGE)--intra- and inter-individual variability in chronic hemodialysis patients. Scand J Clin Lab Invest (2012) 0.75
[Inflammatory bowel disease and pregnancy]. Cas Lek Cesk (2010) 0.75
Proactive approach at the limits of viability improves the short-term outcome of neonates born after 23 weeks' gestation. J Perinat Med (2017) 0.75